Journal
BLOOD CELLS MOLECULES AND DISEASES
Volume 41, Issue 2, Pages 169-174Publisher
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.bcmd.2008.04.006
Keywords
lipocalin 2; anemia; hypoxia; erythropoietin; iron
Categories
Funding
- Canadian Institutes of Health Research [MOP44045]
- Natural Sciences and Engineering Research Council of Canada [298518-06]
- Fonds de la recherche en sante du Quebec
Ask authors/readers for more resources
Lipocalin 2 (Lcn2), a mammalian protein that is expressed and secreted in Various pathologic states, binds siderophores, which are high-affinity iron chelators. Besides its role in limiting iron availability to pathogens in the setting of bacterial infection, Lcn2:siderophore complexes can also deliver it-on to cells. In this Study, we examined Lcn2 regulation in the liver of mice in situations of increased iron utilization, namely, during anemia. Anemia induced by phlebotomy, iron deprivation, or phenylhydrazine treatment was associated with upregulation of Lcn2 gene expression in the liver and elevation of serum Lcn2 protein levels. We further explored the participation of several factors known to co-occur during anemia, including hypoxia, changes in iron levels, and erythropoietic drive, in the regulation of Lcn2 by anemia. We found that hypoxia, but not iron or erythropoietin, Caused an induction of Lcn2 expression. The upregulation of Lcn2 levels by anemia and hypoxia, which is not directly mediated by iron or erythropoietin, Suggests a possible physiological role for Lcn2 during increased iron utilization and mobilization from stores. (C) 2008 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available